Viewing Study NCT05016661


Ignite Creation Date: 2025-12-24 @ 1:01 PM
Ignite Modification Date: 2025-12-30 @ 7:09 PM
Study NCT ID: NCT05016661
Status: TERMINATED
Last Update Posted: 2024-09-20
First Post: 2021-08-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Extension Study of ABP-20001 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 for Migraine Prevention
Sponsor: AEON Biopharma, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module